Bellevue Life Sciences Stock Buy Hold or Sell Recommendation
| BLAC Stock | 11.17 0.09 0.80% |
Given the investment horizon of 90 days and your below-average risk tolerance, our recommendation regarding Bellevue Life Sciences is 'Cautious Hold'. Macroaxis provides Bellevue Life buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BLAC positions.
Check out Bellevue Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bellevue and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bellevue Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Bellevue |
Execute Bellevue Life Buy or Sell Advice
The Bellevue recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bellevue Life Sciences. Macroaxis does not own or have any residual interests in Bellevue Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bellevue Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Bellevue Life Trading Alerts and Improvement Suggestions
| Bellevue Life generates negative cash flow from operations | |
| Bellevue Life has a frail financial position based on the latest SEC disclosures | |
| About 50.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: On The My Stocks Page - Stock Traders Daily |
Bellevue Life Returns Distribution Density
The distribution of Bellevue Life's historical returns is an attempt to chart the uncertainty of Bellevue Life's future price movements. The chart of the probability distribution of Bellevue Life daily returns describes the distribution of returns around its average expected value. We use Bellevue Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bellevue Life returns is essential to provide solid investment advice for Bellevue Life.
| Mean Return | 0.06 | Value At Risk | -0.8 | Potential Upside | 0.74 | Standard Deviation | 1.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bellevue Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bellevue Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bellevue Life or Capital Markets sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bellevue Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bellevue stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.07 | |
β | Beta against Dow Jones | -0.16 | |
σ | Overall volatility | 1.66 | |
Ir | Information ratio | -0.05 |
Bellevue Life Volatility Alert
Bellevue Life Sciences has relatively low volatility with skewness of 4.56 and kurtosis of 35.54. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bellevue Life's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bellevue Life's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bellevue Life Fundamentals Vs Peers
Comparing Bellevue Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bellevue Life's direct or indirect competition across all of the common fundamentals between Bellevue Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bellevue Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bellevue Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bellevue Life to competition |
| Fundamentals | Bellevue Life | Peer Average |
| Return On Asset | -0.0298 | -0.14 |
| Current Valuation | 47.27 M | 16.62 B |
| Shares Outstanding | 4.04 M | 571.82 M |
| Shares Owned By Insiders | 50.49 % | 10.09 % |
| Shares Owned By Institutions | 42.94 % | 39.21 % |
| Number Of Shares Shorted | 766 | 4.71 M |
| Price To Book | 3.05 X | 9.51 X |
| EBITDA | 944.59 K | 3.9 B |
| Net Income | 403.78 K | 570.98 M |
| Total Debt | 4.11 M | 5.32 B |
| Book Value Per Share | (0.69) X | 1.93 K |
| Cash Flow From Operations | (818.77 K) | 971.22 M |
| Short Ratio | 0.04 X | 4.00 X |
| Earnings Per Share | (0.09) X | 3.12 X |
| Market Capitalization | 45.5 M | 19.03 B |
| Total Asset | 36.63 M | 29.47 B |
| Retained Earnings | (3.91 M) | 9.33 B |
| Working Capital | (2.02 M) | 1.48 B |
| Net Asset | 36.63 M |
Note: Insider Trading [view details]
Bellevue Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bellevue . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Bellevue Life Buy or Sell Advice
When is the right time to buy or sell Bellevue Life Sciences? Buying financial instruments such as Bellevue Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bellevue Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Preferred Stock ETFs Thematic Idea Now
Preferred Stock ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Preferred Stock ETFs theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Preferred Stock ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Bellevue Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellevue Life. If investors know Bellevue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellevue Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Return On Assets (0.03) |
The market value of Bellevue Life Sciences is measured differently than its book value, which is the value of Bellevue that is recorded on the company's balance sheet. Investors also form their own opinion of Bellevue Life's value that differs from its market value or its book value, called intrinsic value, which is Bellevue Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellevue Life's market value can be influenced by many factors that don't directly affect Bellevue Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellevue Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bellevue Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellevue Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.